BRIEF published on 12/11/2025 at 07:05, 3 months 16 days ago Innate Pharma reveals its 2026 financial calendar Biotechnology Financial Calendar Immunotherapy Innate Pharma 2026 Results
BRIEF published on 12/11/2025 at 07:05, 3 months 16 days ago Innate Pharma révèle son calendrier financier 2026 Biotechnologie Calendrier Financier Immunothérapie Innate Pharma Résultats 2026
BRIEF published on 12/11/2025 at 07:05, 3 months 16 days ago Innate Pharma annonce son calendrier financier pour 2026 Biotechnologie Calendrier Financier Informations Pour Les Investisseurs Innate Pharma Dates Clés De 2026
BRIEF published on 12/11/2025 at 07:05, 3 months 16 days ago Innate Pharma Announces 2026 Financial Calendar Biotechnology Investor Information Innate Pharma Financial Schedule 2026 Key Dates
PRESS RELEASE published on 12/11/2025 at 07:00, 3 months 16 days ago Informations privilégiées / Autres communiqués Innate Pharma publie son calendrier financier pour 2026, incluant la publication des résultats annuels et semestriels, ainsi que des chiffres d'affaires trimestriels Chiffre D'affaires Calendrier Financier Résultats Annuels Innate Pharma Immunothérapies
PRESS RELEASE published on 12/11/2025 at 07:00, 3 months 16 days ago Inside Information / Other news releases Innate Pharma releases its 2026 financial calendar, including key dates for financial statements and shareholder meetings. Find details on the company's website Euronext Financial Calendar Nasdaq Innate Pharma 2026
BRIEF published on 11/28/2025 at 07:05, 3 months 29 days ago New number of shares and voting rights of Innate Pharma Euronext Paris Share Capital Nasdaq Innate Pharma Shares And Rights
BRIEF published on 11/28/2025 at 07:05, 3 months 29 days ago Nouveau nombre d'actions et droits de vote d'Innate Pharma Euronext Paris Capital Social Nasdaq Innate Pharma Actions Et Droits
PRESS RELEASE published on 11/28/2025 at 07:00, 3 months 29 days ago Informations privilégiées / Autres communiqués Innate Pharma communique le nouveau nombre d'actions et de droits de vote au 27 novembre 2025 selon la réglementation en vigueur avec 92 196 523 actions ordinaires et 92 962 943 droits de vote théoriques Droits De Vote Actions AMF Innate Pharma Biotechnologies
BRIEF published on 11/17/2025 at 07:05, 4 months 10 days ago Innate Pharma présentera ses travaux lors de la conférence mondiale sur les soins de santé de Jefferies. Biotechnologie Immunothérapie Innate Pharma Conférence Jefferies Thérapeutiques Par Anticorps
Published on 03/26/2026 at 23:00, 8 hours 36 minutes ago FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 9 hours 31 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 9 hours 36 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 9 hours 36 minutes ago Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 10 hours 36 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/27/2026 at 07:00, 36 minutes ago Edisun Power Europe AG: Demanding year reinforces the urgency of advancing the ‘Renewables to AI’ strategy
Published on 03/27/2026 at 07:00, 36 minutes ago Edisun Power Europe AG: Résultat annuel difficile soulignent la nécessité de la nouvelle stratégie « Renewables to AI »
Published on 03/27/2026 at 07:00, 36 minutes ago AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network Holding SA publishes 2025 results and accelerates the expansion of its integrated care model
Published on 03/27/2026 at 07:00, 36 minutes ago AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network Holding SA publie ses résultats 2025 et accélère le déploiement de son modèle de soins intégrés
Published on 03/27/2026 at 06:00, 1 hour 36 minutes ago Fewer orders and lower sales - US tariffs, currency effects and cost pressure weigh on earnings
Published on 03/27/2026 at 07:00, 36 minutes ago WEB SA - CONVOCATION ASSEMBLEE GENERALE ORDINAIRE EXERCICE 2025 - 28/04/2026
Published on 03/26/2026 at 18:17, 13 hours 19 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 13 hours 19 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 13 hours 36 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
